Oral Microbiota and Porphyromonas gingivalis Kgp Genotypes Altered in Parkinson’s Disease with Mild Cognitive Impairment-Reference-Cited by-同舟云学术

Oral Microbiota and Porphyromonas gingivalis Kgp Genotypes Altered in Parkinson’s Disease with Mild Cognitive Impairment

Published:2024-03-27 Issue: Volume: Page:
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Li Dongcheng^ORCID,Ren Tengzhu^ORCID,Li Hao^ORCID,Huang Mingdi^ORCID,Chen Jiaxin^ORCID,He Qishan^ORCID,Lv Wei^ORCID,Liu Hailing^ORCID,Xu Renshi^ORCID,Zhang Xiong^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12035-024-04119-2.pdf

Reference35 articles.

1. Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH et al (2017) Mild cognitive impairment as a risk factor for Parkinson’s disease dementia. Movement Disord 32(7):1056–1065. https://doi.org/10.1002/mds.27002

2. Pedersen KF, Larsen JP, Tysnes O, Alves G (2017) Natural course of mild cognitive impairment in Parkinson disease. Neurology 88(8):767–774. https://doi.org/10.1212/WNL.0000000000003634

3. Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson’s disease dementia: which is more important? Brain 134(5):1493–1505. https://doi.org/10.1093/brain/awr031

4. Irwin DJ, Lee VMY, Trojanowski JQ (2013) Parkinson’s disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. Nat Rev Neurosci 14(9):626–636. https://doi.org/10.1038/nrn3549

5. Pereira PAB, Aho VTE, Paulin L, Pekkonen E, Auvinen P, Scheperjans F (2017) Oral and nasal microbiota in Parkinson’s disease. Parkinsonism Relat D 38:61–67. https://doi.org/10.1016/j.parkreldis.2017.02.026